The Challenges Facing Canadian Trialists in an Increasingly Competitive Global Market: What Can be Done to Remain Competitive?
Globally, the pharmaceutical industry is condensing into fewer, larger international corporations. This has occurred with the vaccine industry in Canada, where two domestic producers have been absorbed by international companies. This changes the relationship between Canadian vaccine researchers and...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2007-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2007/635372 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849405395139821568 |
|---|---|
| author | David W Scheifele Scott A Halperin Brian Ward Bernard Duval |
| author_facet | David W Scheifele Scott A Halperin Brian Ward Bernard Duval |
| author_sort | David W Scheifele |
| collection | DOAJ |
| description | Globally, the pharmaceutical industry is condensing into fewer, larger international corporations. This has occurred with the vaccine industry in Canada, where two domestic producers have been absorbed by international companies. This changes the relationship between Canadian vaccine researchers and corporate head office research directors, who carefully assign prelicensure studies to potential market countries around the globe. To succeed in attracting prelicensure vaccine studies, Canadian researchers need to be outstanding in quality, reliability and efficiency. The present article highlights strategies to help researchers remain internationally competitive for industry-sponsored pharmaceutical studies. |
| format | Article |
| id | doaj-art-4e51c872e217432fa8195b4d125c16e4 |
| institution | Kabale University |
| issn | 1712-9532 |
| language | English |
| publishDate | 2007-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-4e51c872e217432fa8195b4d125c16e42025-08-20T03:36:41ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322007-01-0118320520810.1155/2007/635372The Challenges Facing Canadian Trialists in an Increasingly Competitive Global Market: What Can be Done to Remain Competitive?David W Scheifele0Scott A Halperin1Brian Ward2Bernard Duval3The Canadian Association for Immunization Research & Evaluation, Vancouver, British Columbia, CanadaThe Canadian Association for Immunization Research & Evaluation, Vancouver, British Columbia, CanadaThe Canadian Association for Immunization Research & Evaluation, Vancouver, British Columbia, CanadaThe Canadian Association for Immunization Research & Evaluation, Vancouver, British Columbia, CanadaGlobally, the pharmaceutical industry is condensing into fewer, larger international corporations. This has occurred with the vaccine industry in Canada, where two domestic producers have been absorbed by international companies. This changes the relationship between Canadian vaccine researchers and corporate head office research directors, who carefully assign prelicensure studies to potential market countries around the globe. To succeed in attracting prelicensure vaccine studies, Canadian researchers need to be outstanding in quality, reliability and efficiency. The present article highlights strategies to help researchers remain internationally competitive for industry-sponsored pharmaceutical studies.http://dx.doi.org/10.1155/2007/635372 |
| spellingShingle | David W Scheifele Scott A Halperin Brian Ward Bernard Duval The Challenges Facing Canadian Trialists in an Increasingly Competitive Global Market: What Can be Done to Remain Competitive? Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | The Challenges Facing Canadian Trialists in an Increasingly Competitive Global Market: What Can be Done to Remain Competitive? |
| title_full | The Challenges Facing Canadian Trialists in an Increasingly Competitive Global Market: What Can be Done to Remain Competitive? |
| title_fullStr | The Challenges Facing Canadian Trialists in an Increasingly Competitive Global Market: What Can be Done to Remain Competitive? |
| title_full_unstemmed | The Challenges Facing Canadian Trialists in an Increasingly Competitive Global Market: What Can be Done to Remain Competitive? |
| title_short | The Challenges Facing Canadian Trialists in an Increasingly Competitive Global Market: What Can be Done to Remain Competitive? |
| title_sort | challenges facing canadian trialists in an increasingly competitive global market what can be done to remain competitive |
| url | http://dx.doi.org/10.1155/2007/635372 |
| work_keys_str_mv | AT davidwscheifele thechallengesfacingcanadiantrialistsinanincreasinglycompetitiveglobalmarketwhatcanbedonetoremaincompetitive AT scottahalperin thechallengesfacingcanadiantrialistsinanincreasinglycompetitiveglobalmarketwhatcanbedonetoremaincompetitive AT brianward thechallengesfacingcanadiantrialistsinanincreasinglycompetitiveglobalmarketwhatcanbedonetoremaincompetitive AT bernardduval thechallengesfacingcanadiantrialistsinanincreasinglycompetitiveglobalmarketwhatcanbedonetoremaincompetitive AT davidwscheifele challengesfacingcanadiantrialistsinanincreasinglycompetitiveglobalmarketwhatcanbedonetoremaincompetitive AT scottahalperin challengesfacingcanadiantrialistsinanincreasinglycompetitiveglobalmarketwhatcanbedonetoremaincompetitive AT brianward challengesfacingcanadiantrialistsinanincreasinglycompetitiveglobalmarketwhatcanbedonetoremaincompetitive AT bernardduval challengesfacingcanadiantrialistsinanincreasinglycompetitiveglobalmarketwhatcanbedonetoremaincompetitive |